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ABSTRACT
Objective: Pulmonary arterial hypertension (PAH) is one of the leading causes of death in 
systemic sclerosis (SSc). Current screening algorithms are hampered by low positive predictive 
values. Outcome measures that could futurely add to performance characteristics would be very 
welcome. Against this background, we aim to evaluate the role of nailfold videocapillaroscopy 
(NVC) using standardized definitions, in SSc related PAH (SSc-PAH).
Methods: A systematic review to identify original research papers documenting an association 
between NVC and right heart catheterisation defined SSc-PAH was performed according to the 
PRISMA guidelines. Subsequently, NVC parameters were subdivided into quantitative 
(capillary density, dimension, morphology, and haemorrhages), semi-quantitative and 
qualitative assessment (NVC pattern), according to the definitions of the EULAR Study Group 
on Microcirculation in Rheumatic Diseases.
Results: The systematic search identified 316 unique search results, of which 5 were included 
in the final qualitative analysis. The occurrence of incident SSc-PAH unequivocally associated 
in 2 longitudinal studies with progressive capillary loss (p=0.04 and p=0.033) and the 
progression to a severe (active/late) NVC pattern (p=0.05/0.01 and HR=5.12, 95%CI: 1.23-
21.27). In 3 cross-sectional studies, SSc-PAH was found to be unequivocally inversely 
associated with capillary density (p=0.001 and p<0.05) and associated with the presence of a 
severe NVC pattern (p=0.03 and p<0.05). 
Conclusion: This is the first systematic literature review investigating the role of NVC in SSc-
PAH using standardized description. Unequivocal associations were found between (incident) 
SSc-PAH and capillary density and NVC pattern. Integration of NVC into current screening 
algorithms to boost their performance may be a future step.
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ABBREVIATIONS
ACCF: American College of Cardiology Foundation
ACR: American College of Rheumatology
AHA: American Heart Association
CI: Confidence Interval
ERS: European Respiratory Society
ESC: European Society of Cardiology 
EULAR: European League against Rheumatism
EULAR SG MC/RD: EULAR Study Group on Microcirculation in Rheumatic Diseases
HR: Hazards Ratio
IPAH: Idiopathic Pulmonary Arterial Hypertension
mPAP: mean Pulmonary Arterial Pressure
NIH: National Institute of Health
NVC: Nailfold Videocapillaroscopy
SSc-noPAH: Systemic Sclerosis without Pulmonary Arterial Hypertension
SSc-PAH: Systemic Sclerosis related Pulmonary Arterial Hypertension
PAH: Pulmonary Arterial Hypertension
PCWP: Pulmonary Capillary Wedge Pressure
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
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1. INTRODUCTION
Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by micro-
vasculopathy and fibrosis of skin and visceral organs. Vascular changes are ubiquitous in the 
small and medium-sized vessels (capillaries and arterioles) of patients with SSc. The lesions 
are marked by loss of endothelial cells, intimal and periadventitial fibrosis, medial 
hypertrophy/hyperplasia and perivascular mononuclear cell infiltration. In SSc, these structural 
changes might be seen in both the peripheral vessels and the pulmonary arteries (1). Pulmonary 
arterial hypertension (PAH) is a leading cause of death in SSc (2, 3). Even though no cure is 
available, yet timely detection of pulmonary involvement and subsequent initiation of 
appropriate therapies might slow down its progression. Hence, early detection may be 
convenient (4-6). Current screening algorithms have a high negative predictive value but 
unfortunately a low positive predictive value, both in unselected SSc patients as well as high 
risk SSc patients, more specifically: 6% for the DETECT algorithm and 11% for the 2015 
European Society of Cardiology (ESC)/ European Respiration Society (ERS) guidelines in 
unselected SSc patients and 47% and 40% respectively in high risk SSc patients (7-9). Outcome 
measures that would futurely add to their performance characteristics may be very welcome (10). 
Conceivably nailfold videocapillaroscopy (NVC), a non-invasive tool that allows reliable 
morphological evaluation of the peripheral microcirculation, may be such an outcome measure 
(11-14). Past decades it has taken up a clear role in Raynaud’s Phenomenon (RP) (15-17). In 
this way it is the tool with the highest performance characteristics to discern a primary from a 
secondary RP and in between others it has also been incorporated in the 2013 American College 
of Rheumatology (ACR)/ European League Against Rheumatism (EULAR) classification 
criteria for SSc (18, 19). Against this background the EULAR Study Group on Microcirculation 
in Rheumatic Diseases (EULAR SG MC/RD) felt it timely to investigate whether 
capillaroscopy has been associated with SSc related PAH (SSc-PAH). If such would be the 










































The Journal of on O tober 4, 2019 - Published by www.jrheum.orgDownl aded from 
9
case, then it might be a candidate covariable in future studies trying to ameliorate the 
performance characteristics of existing algorithms. Hence, the study described herein is a 
systematic literature review to assess what is known about NVC and SSc-PAH diagnosed with 
right heart catheterization and stipulating whether the retained literature met the at that moment 
available guidelines on pulmonary hypertension (9, 20-22). Moreover, the NVC results will be 
described, for reasons of international standardization and comparability of study results, 
through the EULAR SG MC/RD consented simple standardized capillaroscopic definitions to 
describe and report NVC characteristics (23-26). 
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2. MATERIAL AND METHODS
2.1.Data source and search strategy
The systematic literature review was designed in accordance with the Preferred Reporting Items 
for Systematic reviews and Meta-Analyses (PRISMA) guidelines in order to identify all full-
text manuscripts that document an association between NVC and SSc-PAH diagnosed with 
right heart catheterization (9, 20-22, 27). The search of Pubmed, EMBASE and Web of Science 
was conducted based on a combination of following keywords: ‘nailfold videocapillaroscopy’, 
‘systemic sclerosis’ and ‘pulmonary arterial hypertension’. The search was performed without 
limitation of date of publication, up to the 4th of July 2018. The systematic search was last 
updated on the 15th of January 2019. For the 3 searches, keywords referred to keywords present 
in the title/abstract. Details on the complete search strategy are shown in supplementary file 1.
2.2.Screening process and selection criteria
First, after deleting duplicates, 2 investigators (AV, MG) independently screened the records 
identified by database search on title, abstract and full-text level, with regard to inclusion and 
exclusion criteria. Second, both reviewers manually searched the reference lists of the retained 
full-texts for supplementary records and applied the same screening process. During the title 
and abstract screening process, records were considered eligible when both investigators 
included them for the next step. When different opinions existed among the 2 investigators 
about whether to include a record for the qualitative analysis, consensus was reached by 
discussing those disagreements with an expert (VS). 
Records were selected if they were original prospective longitudinal or cross-sectional studies 
documenting the use of NVC in SSc-PAH diagnosed with right heart catheterization, with a 
minimum sample of 5 SSc patients. Reviews, letters, editorials, abstracts of scientific 
congresses, case studies (n < 5) and retrospective studies were noted but not included. 
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Languages other than English, Dutch and French were excluded. Studies that were not available 
in full-text version format were also excluded. Subsequent to the screening process, relevant 
data were extracted and analysed by the same 2 investigators and discussed both with the 
academic cardiologist (EV) and the first author (VS). The following data were extracted using 
a standardized electronic spreadsheet designed for this systematic review: author, year, country 
of origin, objective, study design, classification criteria, study population size (number of 
patients and controls, mean age), disease subset, NVC technique, assessment and evaluation, 
right heart catheterization parameters, statistical analysis and results.
2.3.Quality appraisal 
All selected original studies underwent methodological quality assessment by the same 2 
investigators, using the National Institute of Health (NIH) tool for observational cohort and 
cross-sectional studies (see supplementary file 2) (28). Consensus on the scores was reached 
and discrepancies were resolved through discussion.
2.4.Evaluation of nailfold videocapillaroscopic assessment
NVC assessment was described, as per consensus of the EULAR SG MC/RD (23-26).
Quantitative assessment was evaluated as follows: number of capillaries per linear millimetre 
(i.e. capillary density), number of giant capillaries (dilation > 50µm) per linear millimetre (i.e. 
capillary dimension), presence of capillary bleeding (i.e. haemorrhages) and number of 
abnormally shaped (not hairpin-shaped, not tortuous, > 2 crossings, no convex head) capillaries 
per linear millimetre (i.e. abnormal capillary morphology) (23-26). 
Semi-quantitative assessment was described as defined per study. 
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Qualitative assessment was evaluated as defined by Cutolo et al., classifying images as having 
a “normal”, “non-specific”, “early”, “active” or “late” NVC scleroderma pattern (25, 29).
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3. RESULTS
3.1.Systematic search and screening process
The systematic search identified 44 records in MEDLINE (PubMed), 208 in EMBASE and 64 
in Web of Science. Primary electronic database searching identified 234 records after the 
removal of duplicates and an additional 3 records were retrieved after reference list searching. 
Full-text review was performed on 28 records, to finally retain 5 original studies eligible for 
qualitative analysis (see figure 1 for the flowchart). Two of the included articles were 
longitudinal studies, the others were cross-sectional studies. Table 1 contains the most 
important demographic characteristics of the 5 included studies, altogether comprising 281 SSc 
patients (64 SSc-PAH and 217 SSc-noPAH) from 3 different European countries.
3.2.Quality appraisal
The methodological quality ratings according to the NIH are presented in supplementary file 2. 
Of the 5 selected articles, 2 articles were rated to have good quality and 3 to have a fair quality. 
Of note, aiming to descriptively present the existing literature concerning NVC and SSc-PAH, 
no articles were excluded solely based on their quality. 
3.3.Longitudinal studies
Two longitudinal studies, investigating the prognostic value of NVC alterations as a primary 
outcome in SSc patients, were included in this systematic literature review (30, 31). Both of 
them described a right heart catheterization definition of SSc-PAH and Avouac stated the 2009 
ESC/ESR guidelines had been followed to screen for PAH (21, 30, 31). Both articles were 
judged to have a good quality (see Supplementary File 2) (28). NVC examination and 
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assessment were similarly performed in both studies at baseline and during follow-up, using a 
videocapillaroscope with a 200x magnification contact lens connected to image analysis 
software (30, 31). Subsequently, NVC images were assessed both quantitatively and 
qualitatively (30, 31). 
Sulli et al. undertook a longitudinal medium-term study with a medium follow-up of 84 months 
in 38 SSc patients with an early NVC pattern at baseline, to investigate the timing of transition 
through different NVC patterns (30). At the end of follow-up, 4 patients (2 with active and 2 
with late NVC pattern) presented SSc-PAH confirmed by right heart catheterization (“mPAP > 
25 mmHg”) (21, 30). Concerning the progression of quantitative NVC findings during follow-
up, SSc-PAH significantly correlated with loss of capillaries (p = 0.04) and abnormal capillary 
morphology (p = 0.04). No statistical significant correlation has been reported between SSc-
PAH and capillary dimension or presence of haemorrhages (30). Concerning qualitative NVC 
assessment, the occurrence of SSc-PAH was found more frequently in those patients who 
progressed from an early to either an active or a late NVC pattern at the end of follow-up (p = 
0.05 and p = 0.01, respectively) (30). 
In the second longitudinal study, an unselected cohort of 140 consecutive SSc patients was 
prospectively followed up during 3 years by Avouac et al., to determine the association of NVC 
alterations with organ progression in SSc, including SSc-PAH (31). During the 3-year follow-
up period, SSc-PAH as confirmed by right heart catheterization (mPAP ≥ 25 mmHg and PCWP 
≤ 15 mmHg) was observed in 8 patients (21, 31). Concerning the quantitative NVC assessment 
at inclusion, solely neoangiogenesis (abnormal capillary morphology) reached statistical 
significance in univariate Cox analysis (HR = 7.38, 95% CI: 1.44-37.73, p = 0.017) and could 
be confirmed by multivariate analysis with additional stratification on disease duration as an 
independent risk factor for the occurrence of PAH (HR = 11.12, 95% CI: 1.19-103.79, p = 
0.036) (31). In the univariate Cox analysis, capillary loss (capillary density) nor presence of 
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giants (capillary dimension) or presence of haemorrhages were found to be predictive for the 
occurrence of PAH (p = 0.074; p = 0.638; p = 0.969; respectively) (31). Concerning the 
progression of quantitative NVC findings during the 3 year follow-up, only progressive loss of 
capillaries reached statistical significance in both univariate (HR = 4.85, 95% CI: 1.17-20.20, 
p = 0.031) and multivariate analysis (HR = 18.53, 95% CI: 1.28-78.33, p = 0.033), meaning 
that progressive loss of capillaries was identified to be strongly predictive for the occurrence of 
SSc-PAH (31). Progression of the number of giant capillaries (capillary dimension), nor 
progression of neoangiogenesis (abnormal capillary morphology) or progression of presence of 
haemorrhages could reach statistical significance in the univariate Cox analysis (p = 0.062; p = 
0.872; p = 0.443. Hence, these progressive quantitative NVC parameters were not identified as 
predictive markers for the occurrence of SSc-PAH (31). 
Of note, considering the qualitative NVC assessment, worsening from a normal, early or active 
to a late NVC pattern was associated with the occurrence of SSc-PAH (HR = 5.12 95% CI: 
1.23–21.27) (31).
3.4. Cross-sectional studies
Associations between NVC alterations as a primary outcome in SSc patients with SSc-PAH as 
determined by right heart catheterization was studied in 3 cross-sectional studies (32-34). All 
three described a right heart catheterization definition of SSc-PAH according the at that moment 
available guidelines on pulmonary hypertension The quality of the cross-sectional studies was 
considered fair, according to the NIH qualitative assessment tool for observational cohort and 
cross-sectional studies (see Supplementary File 2) (28). 
Hofstee et al. studied between September 2006 and July 2007 capillary density and dimensions 
and their association with pulmonary hemodynamic parameters in 21 healthy controls (HCs), 
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20 patients with idiopathic PAH (IPAH) and 40 SSc patients, of which 21 had SSc-PAH as 
determined by right heart catheterization (“mPAP > 25 mmHg”) (20, 32). Unlike the other 
cross-sectional studies, a computer-based panorama mosaic videocapillaroscope was used for 
NVC examination and assessment (32, 35). The authors reported a significantly lower capillary 
density in patients with SSc-PAH, compared to those with SSc-noPAH (p = 0.001) (32). No 
statistical significance was reached concerning capillary dimensions (p = 1.000) (32). 
A few years later in 2013, Riccieri et al. evaluated NVC alterations in 12 consecutive SSc-PAH 
patients, as confirmed by right heart catheterization (“mPAP > 25 mmHg”) as well as 12 age- 
and gender matched SSc-noPAH patients (22, 33). NVC examination was performed using a 
videocapillaroscope with a 200x magnification contact lens connected to image analysis 
software (33). The images were semi-quantitatively assessed as follows: a) NVC score, 
combining a semi-quantitative score for density, dimension, presence of haemorrhages and 
morphology (score ranging from 0 = no changes; to 3 = ≥6 alterations per linear millimetre) 
and b) avascular area grading (score ranging from 0 = no obvious avascular areas; to 3 = severe, 
the presence of large, confluent avascular areas) (29, 33, 36). Additionally, qualitative 
assessment was performed, according to Cutolo et al., classifying patients into 
normal/early/active or late NVC pattern (29, 33). Significant correlations were found between 
the presence of SSc-PAH and more severe semi-quantitative assessments: NVC score (p = 0.03) 
and avascular area grading (p = 0.003) (33). Additionally, patients with SSc-PAH showed 
significantly more often a severe (active/late) NVC pattern than those with SSc-noPAH (92% 
vs. 42%, p = 0.03) (33).
Recently in 2017, Corrado et al. evaluated both quantitative and qualitative NVC alterations 
using a videocapillaroscope with 200x magnification, in 25 HCs, 21 patients with IPAH and 39 
consecutive SSc patients, of which 19 had SSc-PAH determined by right heart catheterization 
(mPAP ≥ 25 mmHg, PCWP ≤ 15 mmHg, PVR > 3 WU) (9, 34). Concerning the quantitative 
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NVC assessment in SSc patients, SSc-PAH significantly inversely correlated with capillary 
density (p < 0.05), correlated with both capillary dimension and giants (p < 0.05) and correlated 
with abnormal capillary morphology (p < 0.01) (34). Haemorrhages were equally present in 
SSc patients with and without SSc-PAH (34). Similar to the cross-sectional study of Riccieri et 
al., a severe (active/late) NVC pattern was presented more often in SSc-PAH patients than in 
those with SSc-noPAH (73% vs. 50%, p < 0.05) (34).
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4. DISCUSSION
This is the first systematic review assessing an association between standardly described 
nailfold videocapillaroscopy and systemic sclerosis related pulmonary arterial hypertension, 
defined by right heart catheterization. Even though the literature is not abundant, as only 2 
longitudinal and 3 cross-sectional studies had been retained, it suggests that number of 
capillaries both in cross-sectional as well as in longitudinal studies may be a common 
denominator (30-34). This is useful, given the fact that number of capillaries is the most reliable 
parameter of all assessable capillaroscopic parameters (11). As mentioned before, systemic 
microvascular changes, marked by loss of endothelial cells, intimal and periadventitial fibrosis, 
medial hypertrophy/hyperplasia and perivascular mononuclear cell infiltration, are hallmark 
features of SSc which are detectable with NVC. By comparing capillaroscopic examinations of 
SSc-PAH and SSc-noPAH patients, both Hofstee et al. and Riccieri et al. suggested the 
hypothesis that structural microvascular abnormalities in the peripheral microcirculation in SSc 
patients as detected by NVC, more specifically concerning “capillary density”, may be related 
to the vascular abnormalities in the pulmonary circulation in SSc-PAH (32, 33). Both 
longitudinal studies, by Sulli et al. and Avouac et al., confirmed that progressive loss of 
capillaries over time correlates with incident SSc-PAH (30, 31). Whether the same is true for 
IPAH, a disease lacking evidence for characteristic scleroderma pattern at the nailfolds, remains 
debatable since both Corrado et al. and Hofstee et al. found a lower capillary density in small 
groups of IPAH patients compared to healthy controls (32, 34). Indeed, IPAH and SSc-PAH 
are similar diseases with indistinguishable pulmonary vessel abnormalities, but they present 
clinically different (i.e. SSc-PAH patients demonstrate a poorer response to therapy and have a 
worse long-term survival) (37). 
Hence, we would go for number of capillaries as the new kid on the block covariable to assess 
the option of boosting its positive predictive value of existing algorithms, i.e. the DETECT 
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algorithm (7, 8). Also more severe scleroderma patterns, i.e. active and late scleroderma pattern, 
or a conversion over time to worse scleroderma patterns, are associated with (incident) right 
heart catheterization defined SSc-PAH. Of note, post hoc, after the completion of this 
systematic review, a cross-sectional study by Guillén-Del-Castillo et al. was published, 
reporting a negative correlation of higher capillary density and a positive correlation of number 
of abnormal shapes (“neoangiogenesis”) with right ventricular systolic pressure in SSc-PAH 
patients compared to SSc-noPAH patients (38). 
The low number of retained manuscripts might seem a limitation of this systematic review until 
one realises that the reason for this was our definition that SSc-PAH should have been right 
heart catheterization defined according to the at that moment available guidelines on pulmonary 
hypertension for reasons of interpretability in between studies (9, 20-22). Interpretability of 
results was also our motivation why we have described all NVC studies with the EULAR Study 
Group on Microcirculation in Rheumatic Diseases format facilitating comparability of the 
results throughout the retained manuscripts. 
Of note, 5 manuscripts documenting the use of NVC in SSc-PAH diagnosed with right heart 
catheterization were withheld in this systematic literature review, of which one followed the 
2003 ESC guidelines, one followed the 2009 ESC/ERS guidelines, one followed the 2009 
American College of Cardiology Foundation (ACCF)/ American Heart Association (AHA) 
guidelines and one strictly followed the 2015 ESC/ERS guidelines. Although the remaining 
article which was written by Sulli et al. did not clearly state the followed guidelines, we can 
assume, according to the author definitions, that SSc-PAH was diagnosed by following the 2009 
ESC/ERS guidelines (21). Ideally future studies would rigorously follow PAH screening 
guidelines to avoid underdiagnosis of PAH.
Ideally, the future research agenda of the SSc community might involve, next to standard 
adherence to existing guidelines for screening for PAH in SSc populations (non) “at risk”, also 
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standard evaluation of NVC (26). Only this way, there will be enough power to truly evaluate 
if NVC, and more specifically “capillary density”, is the “new kid on the block” to boost the 
performance characteristics (more specifically to boost the positive predictive value) of existing 
algorithms.
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5. CONCLUSION
Nailfold capillaroscopy may be a new kid on the block and number of capillaries may be “the 
chosen” covariable in future trials assessing how to boost the positive predictive value of 
existing algorithms to predict pulmonary arterial hypertension in SSc patients.
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HIGHLIGHTS
 This is the first systematic literature review investigating the role of NVC in SSc-PAH, 
using standardized definitions consented by the EULAR SG MC/RD.
 Capillary density and (worsening to) a severe NVC pattern are the only NVC characteristics 
associated with the presence or occurrence of incident SSc-PAH.
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APPENDICES
Figure 1: Flowchart systematic review according to PRISMA 2009 guidelines
Table 1: Demographic characteristics of records included in the systematic review
Table 2: SSc-PAH diagnosed according to right heart catheterization criteria – 
LONGITUDINAL studies
Table 3: SSc-PAH diagnosed according to right heart catheterization criteria – CROSS-
SECTIONAL studies
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Supplementary file 2: Quality assessment of the selected articles
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FIGURES
Figure 1: Flowchart systematic review according to PRISMA 2009 guidelines
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Figure 1: Flowchart systematic review according to PRISMA 2009 guidelines










































Data are given as number of selected articles categorized according to 4 different parts of the 
search process: identification, screening, eligibility and inclusion. The format of this figure is 
based on PRISMA 2009 guidelines (25).
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Right heart catheterization 
diagnosis of SSc-PAH 
(mPAP, PCWP, PVR) and 




2012 (IT) (28) Longitudinal (29) 38/0/0 4*/34
(“mPAP > 25mmHg”)





(FR) (30) Longitudinal (17) 140/0/0 8*/132
(mPAP ≥ 25mmHg & 
PCWP ≤ 15mmHg)







sectional (29) 40/20/21 21/19
(“mPAP > 25mmHg”)
















sectional (17) 39/21/25 19/20
(mPAP ≥ 25mmHg 
& PCWP ≤ 15mmHg 
& PVR > 3 WU)




*Occurrence of incident SSc-PAH during follow-up period
ACCF = American College Cardiology Foundation; AHA = American Heart Association; ERS = European 
Respiratory Society; ESC = European Society of Cardiology; HC = healthy control; IPAH = idiopathic pulmonary 
arterial hypertension; mPAP = mean pulmonary arterial pressure; NVC = nailfold videocapillaroscopy; PCWP 
= pulmonary capillary wedge pressure; PVR = pulmonary vascular resistance; SSc = systemic sclerosis; SSc-
noPAH = systemic sclerosis without pulmonary arterial hypertension; SSc-PAH = systemic sclerosis related 
pulmonary arterial hypertension.
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Table 2: SSc-PAH diagnosed according to right heart catheterization criteria – LONGITUDINAL studies
CAPILLAROSCOPIC PARAMETER SIGNIFICANT ASSOCIATION NON-SIGNIFICANT ASSOCIATION CONCLUSION
Capillary loss at 
inclusion





SSc-PAH (p=0.04) (HR=18.53, 95% 
CI: 1.28-78.33, p=0.033) (28, 30)
N/A
Progressive capillary loss was 
unequivocally associated with 
incident SSc-PAH in 2 
longitudinal studies
Presence of giant 
capillaries at inclusion
N/A SSc-PAH (HR=0.68, 95% CI: 
0.28-2.09, p=0.638) (30)
Dimension
Progression of giant 
capillaries










SSc-PAH (p=0.04) (28) SSc-PAH (HR=1.14, 95% CI: 
0.22-5.86, p=0.872) (30)
Abnormal morphology at 
inclusion was more commonly 
associated with incident SSc-
PAH in 1 longitudinal study
Presence of hemorrhages 
at inclusion















N/A SSc-PAH (HR=0.44 95% CI: 
0.05-3.55, p=0.443) (30)
No association

























Progression to a severe NVC pattern 
(active/late vs. normal/early)
SSc-PAH (p=0.05/ p=0.01) (HR=5.12, 
95% CI: 1.23-21.27) (28, 30)
N/A Progression to a severe NVC 
pattern (active/late) was 
unequivocally associated with 
incident SSc-PAH in 2 
longitudinal studies
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inversely associated with 
SSc-PAH in 2 cross-
sectional studies














was more commonly 












Hemorrhages N/A SSc-PAH (NR) 
(33) No association
 NVC score SSc-PAH (p=0.03) 
(32)
N/A NVC score was more 
commonly associated 















Avascular area grade SSc-PAH (p=0.003) 
(32)
N/A Avascular area grade 
was more commonly 
associated with SSc-



















(32) (p<0.05) (33) 
N/A Severe NVC patterns 
(active/late) are 
unequivocally associated 
with SSc-PAH in 2 
cross-sectional studies
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